Reeve Emma Insider Trading Activity
Reeve Emma has been net-selling over the last 12 months with 0 purchases and 19 sales across 1 company.
PTCT is the most-traded position with 19 trades. The largest single transaction was a sale of PTCT for $834K on Oct 30, 2025.
Performance Scorecard
Forward stock performance after each transaction by Reeve Emma. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.9% | 16% | 19 |
| 90 days | — | -11.5% | 21% | 19 |
| 120 days | — | -9.4% | 32% | 19 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersPTCT · PTC THERAPEUTICS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Reeve Emma bought and sold PTCT.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jan 5, 2026 | PTCT | Sell | 734 | $76.00 | $56K | −6.4% | Director | |
Dec 3, 2025 | PTCT | Sell | 733 | $78.62 | $58K | −9.9% | Director | |
Nov 21, 2025 | PTCT | Sell | 10,000 | $79.50 | $795K | −60.0% | Director | |
Nov 12, 2025 | PTCT | Sell | 7,333 | $74.50 | $546K | −52.4% | Director | |
Oct 30, 2025 | PTCT | Sell | 3,666 | $69.50 | $255K | −35.5% | Director | |
Oct 30, 2025 | PTCT | Sell | 12,000 | $69.50 | $834K | −64.3% | Director | |
Oct 3, 2025 | PTCT | Sell | 3,028 | $65.09 | $197K | −14.9% | Director | |
Oct 3, 2025 | PTCT | Sell | 4,591 | $66.09 | $303K | −26.5% | Director | |
Oct 3, 2025 | PTCT | Sell | 2,381 | $66.87 | $159K | −18.7% | Director | |
Oct 3, 2025 | PTCT | Sell | 2,163 | $65.02 | $141K | −12.5% | Director | |
Oct 3, 2025 | PTCT | Sell | 3,149 | $66.11 | $208K | −20.9% | Director | |
Oct 3, 2025 | PTCT | Sell | 1,600 | $66.93 | $107K | −13.4% | Director | |
Oct 3, 2025 | PTCT | Sell | 2,729 | $65.05 | $178K | −14.4% | Director | |
Oct 3, 2025 | PTCT | Sell | 4,037 | $66.10 | $267K | −24.8% | Director | |
Oct 3, 2025 | PTCT | Sell | 1,884 | $66.89 | $126K | −15.4% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 3,534 | $59.50 | $210K | −23.3% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 1,334 | $59.50 | $79K | −11.4% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 10,000 | $59.50 | $595K | −49.2% | Director | |
Sep 11, 2025 Filed 3d late | PTCT | Sell | 837 | $59.50 | $50K | −7.5% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | 19 | $5.2M |
Other insiders at PTC THERAPEUTICS, INC.
9 other tracked filers at PTCT.
VP
65
Trades
CHIEF TECHNICAL OPS OFFICER
49
Trades
CHIEF BUSINESS OFFICER
31
Trades
CEO
13
Trades
Director
12
Trades
VP
6
Trades
VP
4
Trades
CFO
3
Trades
Director
3
Trades